Campbell & Co Investment Adviser’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-18,913
| Closed | -$285K | – | 1288 |
|
|
2024
Q3 | $285K | Buy |
18,913
+1,639
| +9% | +$24.7K | 0.02% | 924 |
|
|
2024
Q2 | $494K | Buy |
17,274
+4,569
| +36% | +$131K | 0.04% | 660 |
|
|
2024
Q1 | $371K | Sell |
12,705
-12,726
| -50% | -$372K | 0.03% | 827 |
|
|
2023
Q4 | $858K | Buy |
25,431
+17,432
| +218% | +$588K | 0.08% | 456 |
|
|
2023
Q3 | $245K | Buy |
+7,999
| New | +$245K | 0.03% | 794 |
|
|
2023
Q2 | – | Sell |
-14,087
| Closed | -$575K | – | 1063 |
|
|
2023
Q1 | $575K | Sell |
14,087
-7,429
| -35% | -$303K | 0.11% | 366 |
|
|
2022
Q4 | $831K | Buy |
+21,516
| New | +$831K | 0.2% | 136 |
|
|
2022
Q3 | – | Sell |
-21,511
| Closed | -$1.25M | – | 872 |
|
|
2022
Q2 | $1.25M | Buy |
+21,511
| New | +$1.25M | 0.34% | 43 |
|
|
2022
Q1 | – | Sell |
-9,566
| Closed | -$576K | – | 853 |
|
|
2021
Q4 | $576K | Buy |
+9,566
| New | +$576K | 0.2% | 159 |
|